ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q1 2017. The put-call ratio across all filers is 2.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $431,000 | -29.0% | 8,892 | -42.7% | 0.10% | +3.0% |
| Q1 2018 | $607,000 | -11.8% | 15,531 | -4.2% | 0.10% | -19.4% |
| Q4 2017 | $688,000 | +11.7% | 16,212 | -1.9% | 0.12% | +8.8% |
| Q3 2017 | $616,000 | -15.0% | 16,521 | -30.8% | 0.11% | -27.8% |
| Q2 2017 | $725,000 | +14.7% | 23,878 | 0.0% | 0.16% | +32.8% |
| Q1 2017 | $632,000 | -6.6% | 23,878 | -10.1% | 0.12% | -7.8% |
| Q4 2016 | $677,000 | -81.7% | 26,565 | -75.5% | 0.13% | -66.1% |
| Q3 2016 | $3,691,000 | -11.7% | 108,632 | -11.7% | 0.38% | +5.2% |
| Q2 2016 | $4,181,000 | +25.0% | 123,065 | -2.9% | 0.36% | +46.6% |
| Q1 2016 | $3,344,000 | +19.7% | 126,726 | +56.1% | 0.25% | +384.3% |
| Q4 2015 | $2,794,000 | – | 81,176 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |